Navigation Links
ERT to Announce Third Quarter 2010 Results on November 4, 2010
Date:10/20/2010

PHILADELPHIA, Oct. 20 /PRNewswire-FirstCall/ -- ERT (Nasdaq: ERES) announced today that it will release its results for the third quarter 2010 on Thursday, November 4, 2010, after the market closes. After the release, the Company will host a conference call at 5:00 PM EDT that day.

For the conference call, interested participants should dial 1-800-860-2442 when calling within the United States or 1-412-858-4600 when calling internationally. There will be a playback available as well. To listen to the playback, please call 1-877-344-7529 when calling within the United States or 1-412-317-0088 when calling internationally.  Conference code for playback is 445264.

This call is being webcast by MultiVu and can be accessed at ERT's website at www.ert.com. The webcast may also be accessed via the direct link at http://www.videonewswire.com/event.asp?id=73223.   The webcast can be accessed for up to one year on either site.  

Based in Philadelphia, PA, eResearchTechnology, Inc. (www.ert.com) is a global provider of technology and services to the pharmaceutical, biotechnology and medical device industries.  The Company is a market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development. It is also a leading provider of centralized respiratory technology and services to evaluate pulmonary function efficacy and safety in clinical development.  Sponsors can further use the Company's solutions to streamline the clinical trials process by automating the collection, analysis, and distribution of ePRO clinical data using multi-mode technology in all phases of clinical development as well as selected medical devices for the clinical trials and healthcare industries.

Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties, which could cause actual results to differ materially from those expressed or implied from such statements. These risks and uncertainties include, without limitation, the Company's ability to obtain new contracts, variability in size, scope, and duration of projects, integration of acquisitions, competitive factors, technological development, market demand, and other factors described in the Company's filings with the Securities and Exchange Commission.  The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.


'/>"/>
SOURCE ERT
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Boston Scientific Announces Results for Third Quarter Ended September 30, 2010
2. ThermoGenesis Announces Platelet Rich Plasma (PRP) Res-Q Cardiovascular Licensing Agreement
3. Amylin, Lilly and Alkermes Announce Receipt of Complete Response Letter from FDA for BYDUREON™
4. Celsion Announces ThermoDoxs Prominence in Abstracts Presented at the 2nd International MR-Guided Ultrasound Symposium
5. Aethlon Medical Announces Appointment of Rod Kenley to Its Board of Directors
6. Sysmex America Announces Amerinet Hematology Contract
7. iGPS Announces iGPS bios™, a New Pallet Rental Service Designed Exclusively for the Pharmaceutical and Life Sciences Industries
8. Accium BioSciences Announces $99 Sample Pricing for Its Accelerator Mass Spectrometry (AMS) Measurement Service
9. Althea Technologies Announces the Installation of a High-Speed Prefilled Syringe Line
10. Transcept Pharmaceuticals Announces Preliminary Results From the Intermezzo® Highway Driving Study
11. CoAxia Announces Results of SENTIS Ischemic Stroke Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... YORK , Jan. 17, 2017 Immune ... stage biopharmaceutical company, announced today that it will hold ... Symposium on Acute Leukemias (ISAL) XVI in ... is entitled:  "Reinforcing the Efficacy of Immunotherapy for the ... take place on Monday February 20 th , 2017 from ...
(Date:1/17/2017)... Jan. 17, 2017 Interpace Diagnostics Group, Inc., (NASDAQ: ... molecular diagnostic tests and pathology services for evaluating risks ... letter dated January 13, 2017 from the NASDAQ Listing ... with the requirement of the NASDAQ Stock Market to ... share. The letter noted that for the ...
(Date:1/17/2017)... -- Research and Markets has announced the addition of the ... offering. ... comprehensive report, identifies and profiles the leading 200 manufacturers and distributors of ... the United States and Europe ... . Profile information for each company in The Top ...
Breaking Medicine Technology:
(Date:1/17/2017)... ... 17, 2017 , ... Metro Development Group has broken ground ... technology into the fabric of an entire community. A highlight of this new ... in a yet-to-be-named, health focused campus. Leading this initiative in partnership with Metro ...
(Date:1/17/2017)... Lehi, Utah (PRWEB) , ... January 17, 2017 ... ... provider of accredited, online continuing education for EMS and firefighting professionals, has released ... Training (VILT) Solution. These new courses are taught live in an online classroom ...
(Date:1/17/2017)... ... ... A prescription medication bottle, pocket knife, luggage and a solar-powered aluminum casting process ... , the Cradle to Cradle Products Innovation Institute has announced. , This ... through early 2018. The challenges are presented by the Institute in partnership with Autodesk ...
(Date:1/17/2017)... CO (PRWEB) , ... January 17, 2017 , ... ... protection and financial planning assistance to families and business professionals throughout central Colorado, ... to regional homeless families. , The Aurora Warms The Night organization is committed ...
(Date:1/17/2017)... ... 17, 2017 , ... Seceon , the only threat ... today announced a strategic partnership with TechLab Security, a leading Enterprise ... TechLab Security has become a strategic partner and a value added reseller of ...
Breaking Medicine News(10 mins):